357 related articles for article (PubMed ID: 28612839)
1. Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.
Silberger DJ; Zindl CL; Weaver CT
Mucosal Immunol; 2017 Sep; 10(5):1108-1117. PubMed ID: 28612839
[TBL] [Abstract][Full Text] [Related]
2. Citrobacter rodentium: infection, inflammation and the microbiota.
Collins JW; Keeney KM; Crepin VF; Rathinam VA; Fitzgerald KA; Finlay BB; Frankel G
Nat Rev Microbiol; 2014 Sep; 12(9):612-23. PubMed ID: 25088150
[TBL] [Abstract][Full Text] [Related]
3. Linking Pathogen Virulence, Host Immunity and The Microbiota at the Intestinal Barrier.
Nunez G
Keio J Med; 2017; 66(1):14. PubMed ID: 28356548
[TBL] [Abstract][Full Text] [Related]
4. Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells.
Pallett MA; Crepin VF; Serafini N; Habibzay M; Kotik O; Sanchez-Garrido J; Di Santo JP; Shenoy AR; Berger CN; Frankel G
Mucosal Immunol; 2017 May; 10(3):602-612. PubMed ID: 27624779
[TBL] [Abstract][Full Text] [Related]
5. The Mouse Model of Infection with Citrobacter rodentium.
Bouladoux N; Harrison OJ; Belkaid Y
Curr Protoc Immunol; 2017 Nov; 119():19.15.1-19.15.25. PubMed ID: 29091261
[TBL] [Abstract][Full Text] [Related]
6. Innate immunity restricts Citrobacter rodentium A/E pathogenesis initiation to an early window of opportunity.
Buschor S; Cuenca M; Uster SS; Schären OP; Balmer ML; Terrazos MA; Schürch CM; Hapfelmeier S
PLoS Pathog; 2017 Jun; 13(6):e1006476. PubMed ID: 28662171
[TBL] [Abstract][Full Text] [Related]
7. Citrobacter rodentium mouse model of bacterial infection.
Crepin VF; Collins JW; Habibzay M; Frankel G
Nat Protoc; 2016 Oct; 11(10):1851-76. PubMed ID: 27606775
[TBL] [Abstract][Full Text] [Related]
8. Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP.
Girard F; Crepin VF; Frankel G
Infect Immun; 2009 Apr; 77(4):1304-14. PubMed ID: 19188355
[TBL] [Abstract][Full Text] [Related]
9. The p50 subunit of NF-kappaB is critical for in vivo clearance of the noninvasive enteric pathogen Citrobacter rodentium.
Dennis A; Kudo T; Kruidenier L; Girard F; Crepin VF; MacDonald TT; Frankel G; Wiles S
Infect Immun; 2008 Nov; 76(11):4978-88. PubMed ID: 18694964
[TBL] [Abstract][Full Text] [Related]
10. Bacterial Adrenergic Sensors Regulate Virulence of Enteric Pathogens in the Gut.
Moreira CG; Russell R; Mishra AA; Narayanan S; Ritchie JM; Waldor MK; Curtis MM; Winter SE; Weinshenker D; Sperandio V
mBio; 2016 Jun; 7(3):. PubMed ID: 27273829
[TBL] [Abstract][Full Text] [Related]
11. TLR9 limits enteric antimicrobial responses and promotes microbiota-based colonisation resistance during Citrobacter rodentium infection.
Yang H; Yu HB; Bhinder G; Ryz NR; Lee J; Yang H; Fotovati A; Gibson DL; Turvey SE; Reid GS; Vallance BA
Cell Microbiol; 2019 Jul; 21(7):e13026. PubMed ID: 30893495
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Citrobacter rodentium colonization: virulence, immune response and microbiota interactions.
Caballero-Flores G; Pickard JM; Núñez G
Curr Opin Microbiol; 2021 Oct; 63():142-149. PubMed ID: 34352594
[TBL] [Abstract][Full Text] [Related]
13. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
El Qaidi S; Wu M; Zhu C; Hardwidge PR
Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.
Thanabalasuriar A; Kim J; Gruenheid S
Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681
[TBL] [Abstract][Full Text] [Related]
15. Utility of the Citrobacter rodentium infection model in laboratory mice.
Borenshtein D; McBee ME; Schauer DB
Curr Opin Gastroenterol; 2008 Jan; 24(1):32-7. PubMed ID: 18043230
[TBL] [Abstract][Full Text] [Related]
16. Protective and destructive innate immune responses to enteropathogenic Escherichia coli and related A/E pathogens.
Lebeis SL; Sherman MA; Kalman D
Future Microbiol; 2008 Jun; 3(3):315-28. PubMed ID: 18505397
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the pst-phoU operon to cell adherence by atypical enteropathogenic Escherichia coli and virulence of Citrobacter rodentium.
Cheng C; Tennant SM; Azzopardi KI; Bennett-Wood V; Hartland EL; Robins-Browne RM; Tauschek M
Infect Immun; 2009 May; 77(5):1936-44. PubMed ID: 19255191
[TBL] [Abstract][Full Text] [Related]
18. Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence.
Lamas B; Michel ML; Waldschmitt N; Pham HP; Zacharioudaki V; Dupraz L; Delacre M; Natividad JM; Costa GD; Planchais J; Sovran B; Bridonneau C; Six A; Langella P; Richard ML; Chamaillard M; Sokol H
Gut; 2018 Oct; 67(10):1836-1844. PubMed ID: 28790160
[TBL] [Abstract][Full Text] [Related]
19. Citrobacter rodentium of mice and man.
Mundy R; MacDonald TT; Dougan G; Frankel G; Wiles S
Cell Microbiol; 2005 Dec; 7(12):1697-706. PubMed ID: 16309456
[TBL] [Abstract][Full Text] [Related]
20. IRE1α-Driven Inflammation Promotes Clearance of Citrobacter rodentium Infection.
Sweet LA; Kuss-Duerkop SK; Keestra-Gounder AM
Infect Immun; 2022 Jan; 90(1):e0048121. PubMed ID: 34748367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
